Retour
Fourchette du Jour
19,53 €
20,33 €
Fourchette 52 Semaines
18,41 €
42,37 €
Volume
2 031 847
Moyenne 50J / 200J
22,84 €
/
29,64 €
Clôture Précédente
19,87 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (626 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | -3,4 | 0,4 |
| P/B | — | 2,9 |
| ROE % | -656,0 | 3,7 |
| Net Margin % | -85,4 | 3,9 |
| Rev Growth 5Y % | 17,6 | 10,0 |
| D/E | — | 0,2 |
Objectif de Cours des Analystes
Hold
49,90 €
+146.2%
Low: 34,00 €
High: 63,00 €
BPA Prévisionnel
-4,36 €
CA Est.
750 M
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2030 |
5,58 €
4,11 € – 7,98 €
|
2,2 B | 4 |
| FY2029 |
3,22 €
2,37 € – 4,60 €
|
1,7 B | 4 |
| FY2028 |
1,30 €
-1,30 € – 5,44 €
|
1,4 B | 11 |
Points Clés
Revenue grew 17,64% annually over 5 years — strong growth
Negative free cash flow of -472,00M
PEG of 0,54 suggests growth is underpriced
Capital efficient — spends only 0,89% of revenue on capex
Croissance
Revenue Growth (5Y)
17,64%
Revenue (1Y)20,13%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Qualité
Return on Equity
-656,03%
ROIC-33,55%
Net Margin-85,44%
Op. Margin-79,49%
Sécurité
Debt / Equity
N/A
Current Ratio2,48
Interest Coverage-8,63
Valorisation
P/E Ratio
-3,41
P/B RatioN/A
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 20,13% | Revenue Growth (3Y) | 24,49% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 17,64% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 673,00M | Net Income (TTM) | -575,00M |
| ROE | -656,03% | ROA | -37,53% |
| Gross Margin | 83,80% | Operating Margin | -79,49% |
| Net Margin | -85,44% | Free Cash Flow (TTM) | -472,00M |
| ROIC | -33,55% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 2,48 |
| Interest Coverage | -8,63 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -3,41 | P/B Ratio | N/A |
| P/S Ratio | 2,91 | PEG Ratio | 0,54 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 1,96B | Enterprise Value | 2,80B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 673,00M | 560,23M | 434,25M | 363,33M | 351,41M |
| Net Income | -575,00M | -569,18M | -606,64M | -707,42M | -454,03M |
| EPS (Diluted) | -5,83 | -6,29 | -8,25 | -10,12 | -6,70 |
| Gross Profit | 564,00M | 483,50M | 389,04M | 335,01M | 335,40M |
| Operating Income | -535,00M | -535,97M | -569,21M | -648,92M | -381,74M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 1,53B | 1,50B | 1,49B | 1,55B | 1,52B |
| Total Liabilities | 1,61B | 1,24B | 1,22B | 1,19B | 599,84M |
| Shareholders' Equity | -80,00M | 255,30M | 275,41M | 352,49M | 922,56M |
| Total Debt | 1,28B | 40,34M | 43,17M | 31,59M | 41,97M |
| Cash & Equivalents | 434,00M | 173,73M | 213,58M | 132,94M | 307,58M |
| Current Assets | 951,00M | 817,12M | 732,18M | 883,90M | 856,60M |
| Current Liabilities | 384,00M | 344,15M | 280,44M | 261,21M | 181,37M |